Search Results

The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.

199 Results Found

Public

AHA Comments on the Remanufacturing of Medical Devices, Draft Guidance for Industry and FDA Staff

AHA comments on the Remanufacturing of Medical Devices, Draft Guidance for Industry and Food and Drug Administration Staff.
Public

AHA Statement to Senate Budget Committee on Alleviating Administrative Burden in Health Care

The AHA provides comments before the Senate Committee on Budget on ways to reduce administrative burden and costs in the health care system.

Telling the Hospital Story

Hospitals and health systems and their teams have been on the front lines battling the COVID-19 pandemic for nearly two years. Hospitals and health care workers have stood strong for their communities, and they have a vital role in our society to keep communities healthy.

AHRMM LUC Comments to the FDA’s Draft Guidance for Select Updates for Unique Device Identification: Policy Regarding Global Unique Device Identification Database Requirements for Certain Devices

The AHRMM LUC members submitted comments and recommendations to the FDA's Draft Guidance for Select Updates for Unique Device Identification: Policy Regarding Global Unique Device Identification Database Requirements for Certain Devices. They recommend that information related to all Class I Medical Devices be included in the GUDID without exception.

Lack of Emergency Lighting

Mitigation tools and resources for emergency lighting in mission critical areas, which is vital and has been a repeated finding by the Joint Commission.

Door Inspection Tool

Trustee Tools
Door Inspection Tool 2019.
Public

AHA Comments on CMS Proposal on Accrediting Organization Oversight

AHA comments on CMS’ proposals to strengthen the agency’s oversight of accrediting organizations.
Member

AHA Letter to UnitedHealthcare RE: Molecular Pathology Reimbursement Policy

AHA addresses UnitedHealthcare’s implementation of its Molecular Pathology Reimbursement Policy on April 1, 2024.
Member

Senate Passes AHA-supported Legislation Repealing Antitrust Exemption for Health Insurers

The Senate passed by voice vote the Competitive Health Insurance Reform Act (H.R. 1418/S. 350), AHA-supported legislation that repeals the McCarran-Ferguson antitrust exemption available to commercial health insurers for anticompetitive conduct.
Public

Rural Advocacy Agenda 2024

The AHA supports policies and legislation that enable rural hospitals to care for their communities. The Rural Advocacy Agenda outlines some key areas of focus for our 2024 advocacy agenda.